SCHWABE STEFAN K.F.

PrivateCIK: 1557657
Location

ROCKVILLE, MD

SCHWABE STEFAN K.F. (Executive Vice President R&D) sold 96.8% of their position (60K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $3.26M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderSCHWABE STEFAN K.F.CIK 1557657
Officer· Executive Vice President R&D
Since Feb 2019
-60K
Net shares
Net seller
$3.26M
Total sold
1
Open market trades
0B · 1S
5
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+20K

Price / share

$7.90

Trade value

$158K

% of position

1016.8%
6/18/2018
1.97K21.97K

Common Stock

Direct
M · Option Exercise

Shares

+40K

Price / share

$9.24

Trade value

$369.60K

% of position

182.1%
6/18/2018
21.97K61.97K

Common Stock

Direct
S · Sale

Shares

60K

Price / share

$54.39

Trade value

$3.26M

% of position

96.8%
6/18/2018
61.97K1.97K
Total

Net shares

+0.00

Net value

-$2.74M

Derivative Transactions2

Employee Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

20K shares

Shares

20K

Strike price

7.90

Held after

0.00

Exercisable

6/18/2018

Employee Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

40K shares

Shares

40K

Strike price

9.24

Held after

0.00

Exercisable

6/18/2018
SCHWABE STEFAN K.F. — Insider Transaction (Form 4) Filed Jun 19, 2018 | Finecho